LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

Search

Agilent Technologies Inc

Suletud

SektorTervishoid

126.3 -0.71

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

125.5

Max

127.37

Põhinäitajad

By Trading Economics

Sissetulek

34M

339M

Müük

37M

1.8B

P/E

Sektori keskmine

26.223

49.712

Aktsiakasum

1.49

Dividenditootlus

0.77

Kasumimarginaal

18.474

Töötajad

18,000

EBITDA

44M

500M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+21.93% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.77%

2.36%

Järgmine tulemuste avaldamine

26. aug 2026

Järgmine dividendimakse kuupäev

22. juuli 2026

Järgmine aktsia dividendi kuupäev (ex-date)

30. juuni 2026

Turustatistika

By TradingEconomics

Turukapital

4.4B

37B

Eelmine avamishind

127.01

Eelmine sulgemishind

126.3

Agilent Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Ettevõttest Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
help-icon Live chat